ArticleDiabetologia2023

Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.

James Yarmolinsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.